BRIEF-Merck KGaA says avelumab alliance with Pfizer on track
October 01, 2015 at 05:12 AM EDT
* Says it and Pfizer started investigating a novel, potential first - in - class bi - functional immunotherapy in clinical trials
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.